Literature DB >> 835671

Metal isotopes used as radioactive indicators of ocular melanoma.

S Packer, R M Lambrecht, D R Christman, A N Ansari, A P Wolf, H L Atkins.   

Abstract

We studied radioactive metal compounds to determine their localization in malignant Greene melanoma in the eye of the Syrian golden hamsters. Scintigraphy of an ocular melanoma was achieved with several radioactive metals: radioactive indium(111In)-bleomycin, radioactive gallium (67Ga)-citrate, and radioactive lead (203Pb)-tris. The 111In-bleomycin had the highest tumor uptake (5.45% dose/g), but not the highest tumor-to-background ratios. The 67Ga-citrate had a maximum tumor uptake of 4.87% dose/g at 48 hours. The 111In-chloride had a melanoma uptake of 2.26% dose/g, while with 203Pbtris the uptake was 1.61% dose/g. These uptake ratios compare favorably with that of radioactive phosphorus (32P)-2.21% dose/g. Noninvasive localization of malignant melanoma in the eye was accomplished with metal isotopes. Detailed analysis of in vitro uptake date by tumor and background tissues revealed the optimum time for scanning and precluded unnecessary trials.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835671     DOI: 10.1016/0002-9394(77)90195-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  [Noncontact detection of intraocular lesions by means of a gamma scintillation camera].

Authors:  H Bockslaff; D Dausch; H Bornemann; L Stöppler; H Hundeshagen
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-09

Review 2.  The 32P test and other methods in the diagnosis of intraocular tumors. (Thesis).

Authors:  R A Van Dijk
Journal:  Doc Ophthalmol       Date:  1978-10-16       Impact factor: 2.379

3.  The reliability of radioactive phosphorus (32P) in the diagnosis of intraocular tumors; experience with 912 patients.

Authors:  P K Lommatzsch; H J Correns; J M Rudolph; U Seiffarth; H Deckart
Journal:  Doc Ophthalmol       Date:  1984-02-29       Impact factor: 2.379

4.  Radiation doses to the eye lens from ocular tumour seeking radiopharmaceuticals.

Authors:  R Weinreich; H Bockslaff
Journal:  Eur J Nucl Med       Date:  1983

5.  Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.

Authors:  H Bockslaff; M Spitznas; I Hahn; G Kloster
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

6.  Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.

Authors:  H Bockslaff; G Kloster; D Dausch; K Schad; H Hundeshagen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

7.  Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives.

Authors:  A van Langevelde; C N Bakker; H J Broxterman; J G Journée-de Korver; F M Kaspersen; J A Oosterhuis; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1983

8.  Potential radiopharmaceuticals for the detection of ocular melanoma. Part II. Iodoquinoline derivatives and 67Ga-citrate.

Authors:  A van Langevelde; C N Bakker; H Boer; T A Ilmer; J A Journée-de Korver; F M Kaspersen; E L Noach; J A Oosterhuis; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1986

9.  Localization of 11C-radiopharmaceuticals in the Greene melanoma of hamsters.

Authors:  J H Turner; M Maziere; D Comar
Journal:  Eur J Nucl Med       Date:  1985

10.  Potential radiopharmaceuticals for the detection of ocular melanoma. Part III. A study with 14C and 11C labelled tyrosine and dihydroxyphenylalanine.

Authors:  A van Langevelde; H D van der Molen; J G Journée-de Korver; A M Paans; E K Pauwels; W Vaalburg
Journal:  Eur J Nucl Med       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.